TRIAD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triad, and what generic alternatives are available?
Triad is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in TRIAD is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIAD?
- What are the global sales for TRIAD?
- What is Average Wholesale Price for TRIAD?
Summary for TRIAD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRIAD at DailyMed |
US Patents and Regulatory Information for TRIAD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | TRIAD | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 089023-001 | Jun 19, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
